SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-20-000088
Filing Date
2020-01-29
Accepted
2020-01-29 17:30:21
Documents
1
Period of Report
2020-01-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 27714
  Complete submission text file 0000904454-20-000088.txt   29021
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3030 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address
VITULLO NICOLE (Reporting) CIK: 0001196863 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 20559210